We'd like your feedback
Your feedback is important to us. It will help us improve the quality of the study information on this site. Please answer both questions.
Contact the study team using the details below to take part. If there are no contact details below please ask your doctor in the first instance.
Dr
Hannah Elizabeth
Wainman
hannah.wainman@bristol.ac.uk
Dr
Hannah Elizabeth
Wainman
hannah.wainman@bristol.ac.uk
Hannah
Wainman
zn19837@bristol.ac.uk
Disorders of skin appendagesGeneral symptoms and signs
This information is provided directly by researchers, and we recognise that it isn't always easy to understand. We are working with researchers to improve the accessibility of this information. In some summaries, you may come across links to external websites. These websites will have more information to help you better understand the study.
Hidradenitis suppurativa (HS) is a chronic, painful, long-term skin condition that causes recurrent or persistent boil-like nodules and tunnels under the skin. Commonly affected sites are the skin folds such as the armpits, groin, or under the bust. It affects 1 in 100 people, although this is likely a conservative estimate as we know it takes a long time for the diagnosis to be made.
Research has shown that pain is the most troublesome symptom reported by patients with HS. It has been highlighted as a key area for future research in HS. Dermatologists need to be better at discussing pain with their patients, its impact on their daily lives and its psychological effects. There is limited research on the best ways to manage pain in HS or how the pain impacts patients.
Some research has been done on pain management in dermatology, but this tends to focus on post-surgical pain. There is little discussion of HS in those that consider chronic painful dermatological conditions.
The aim of this project is to first establish HCPs' views on prescribing analgesia in dermatology and the impact and barriers experienced by patients. This will inform a Delphi process, where people interested in managing HS pain ( patients, dermatologists, primary care HCPs and pain specialists) come together to reach a consensus on managing pain in HS. This will help inform future clinical trials into managing pain in HS.
Start dates may differ between countries and research sites. The research team are responsible for keeping the information up-to-date.
The recruitment start and end dates are as follows:
Observational type: Qualitative;
You can take part if:
You may not be able to take part if:
Patients with HS - under the age of 18 Dermatology HCPs with an interest in HS -HCPs working outside the UK or exclusively in private practice Primary care HCPs who care for patients with HS - HCPs working outside the UK or exclusively in private practice Pain specialists caring for patients with HS - HCPs working outside the UK or exclusively in private practice
Below are the locations for where you can take part in the trial. Please note that not all sites may be open.
Dr
Hannah Elizabeth
Wainman
hannah.wainman@bristol.ac.uk
Hannah
Wainman
zn19837@bristol.ac.uk
Dr
Hannah Elizabeth
Wainman
hannah.wainman@bristol.ac.uk
The study is sponsored by University of Bristol and funded by UK DERMATOLOGY CLINICAL TRIALS NETWORK (UK DCTN) .
Your feedback is important to us. It will help us improve the quality of the study information on this site. Please answer both questions.
Read full details
for Trial ID: CPMS 62942
You can print or share the study information with your GP/healthcare provider or contact the research team directly.
